Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3′,5′-monophosphate signaling by β-arrestin2

Molecular Endocrinology

Volumn 15, Issue 1, 2001, Pages 149-163

  Ferrari, Serge L ^a,b   Bisello, Alessandro ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CYCLIC AMP; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MUTANT PROTEIN; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; HORMONE ACTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; CELL MEMBRANE; COS CELLS; CYCLIC AMP; ENDOCYTOSIS; ENZYME INHIBITORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; MUTATION; PROTEIN KINASE INHIBITORS; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RECEPTORS, PARATHYROID HORMONE; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; STAUROSPORINE; TRANSFECTION;

ANIMALIA;

EID: 0035137316     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.15.1.149     Document Type: Article

References (47)

1. Actions of parathyroid hormone
2. The physiology of parathyroid hormone-related protein
3. Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagon-like peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G protein-linked receptor family
4. Interactions of PTH and PTHrP with the PTH/PTHrP receptor and with downstream signaling pathways: Exceptions that provide the rules
5. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia
6. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia
7. Constitutive activation of the cyclic adenosine 3′,5′-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia
8. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors
9. Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide
10. The role of receptor kinases and arrestins in G protein-coupled receptor regulation
11. G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization
12. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves β-arrestin2. Real-time monitoring by fluorescence microscopy
13. Down-regulation of protein kinase C by parathyroid hormone and mezerein differentially modulates cAMP production and phosphate transport in opossum kidney cells
14. A β-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation
15. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia
16. Clathrin and HA2 adaptors: Effects of potassium depletion, hypertonic medium, and cytosol acidification
17. The cytoplasmic tail of the G-protein-coupled receptor for parathyroid hormone and parathyroid hormone-related protein contains positive and negative signals for endocytosis
18. Identification of phosphorylation sites in the G protein-coupled receptor for parathyroid hormone. Receptor phosphorylation is not required for agonist-induced internalization
19. Agonist-dependent phosphorylation of the parathyroid hormone/parathyroid hormone-related peptide receptor
20. Truncation of the carboxyl-terminal region of the rat parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of adenylyl cyclase but not phospholipase C
21. Defects in G protein-coupled signal transduction in human disease
22. Agonist-independent regulation of constitutively active G-protein-coupled receptors
23. Constitutive activation of opsin: Interaction of mutants with rhodopsin kinase and arrestin
24. Phosphorylation-independent inhibition of parathyroid hormone receptor signaling by G protein-coupled receptor kinases
25. A central role for β-arrestins and clathrin-coated vesicle-mediated endocytosis in β2-adrenergic receptor resensitization
26. Synergistic regulation of β2adrenergic receptor sequestration: Intracellular complement of β-adrenergic receptor kinase and β-arrestin determine kinetics of internalization
27. Synergistic regulation of m2 muscarinic acethylcholine receptor desensitization and sequestration by G protein-coupled receptor kinase-2 and β-arrestin-1
28. Involvement of G protein-coupled receptor kinases and arrestins in desensitization to follicle-stimulating hormone action
29. Characterization of G protein-coupled receptor regulation in antisense mRNA-expressing cells with reduced arrestin levels
30. Rapid protein kinase A-mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells
31. Dynamic regulation of RGS2 in bone: Potential new insights into parathyroid hormone signaling mechanisms
32. Constitutively active α-1b adrenergic receptor mutants display different phosphorylation and internalization features
33. Role of receptor phosphorylation in desensitization and internalization of the secretin receptor
34. Properties of secretin receptor internalization differ from those of the β(2)-adrenergic receptor
35. Cellular trafficking of G proteincoupled receptor/β-arrestin endocytic complexes
36. Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the lutropin/choriogonadotropin receptor
37. Evidence of constitutively active luteinizing hormone/human chorionic gonadotropin receptors are rapidly internalized
38. Regulation of the cellular localization and signaling properties of the α(1B)- and α(1D)-adrenoceptors by agonists and inverse agonists
39. Na+ ions binding to the bradykinin B2 receptor suppress agonist-independent receptor activation
40. Constitutively active mutants of the α2-adrenergic receptor
41. A constitutively active mutant β2-adrenergic receptor is constitutively desensitized and phosphorylated
42. Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration
43. Synthesis of fully active biotinylated analogues of parathyroid hormone and parathyroid hormone-related protein as tools for the characterization of parathyroid hormone receptors
44. Probing the bimolecular interactions of parathyroid hormone and the human parathyroid hormone/parathyroid hormone-related protein receptor. 2. Cloning, characterization, and photoaffinity labeling of the recombinant human receptor
45. Real-time visualization of the cellular redistribution of G protein-coupled receptor kinase 2 and β-arrestin2 during homologous desensitization of the substance P receptor
46. Probing the bimolecular interactions of parathyroid hormone with the human parathyroid hormone/parathyroid hormone-related protein receptor. 1. Design, synthesis and characterization of photoreactive benzophenone-containing analogs of parathyroid hormone
47. Generation and characterization of human kidney cell lines stably expressing recombinant human PTH/PTHrP receptor: Lack of interaction with a C-terminal human PTH peptide